Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Pharmos(PARS) -- Ignore unavailable to you. Want to Upgrade?

To: NeuroInvestment who wrote (923)	6/26/1998 4:53:00 PM
From: Rick Strange	Read Replies (1) \| Respond to of 1491

If PARS/BOL wait till next month do we run the risk of missing the prime Fall allergy season? It takes a little time to bring the sales force up to speed and then a few months to detail all of their potential specialist and longer yet for the G.P. market. Seems to me that they are cutting the time line rather thin.

To: NeuroInvestment who wrote (923)	6/26/1998 5:09:00 PM
From: Tony van Werkhooven	Respond to of 1491

You have me intrigued. What options are being looked at? Here are the possible options that I see: Option 1: Market through B&L sales force- requires a learning curve for the allergy market Option 2: Depend on advertising and mailings to "spread the word" Option 3: Find a partner who currently markets to allergy practitioners. On the surface, it seems that options 1 and 2 are detrimental to Pharmos- much slower sales curve, perhaps never reach its potential. Why would Pharmos consider options 1 or 2? Are there other options to be considered? Thanks Tony